Skip to main content
Top
Published in: Cardiovascular Drugs and Therapy 2/2010

01-04-2010

Hypoxia Inducible Factor-1 Protects Against Nitrate Tolerance and Stunning in Rabbit Cardiac Myocytes

Authors: Tao Tan, Harvey R. Weiss

Published in: Cardiovascular Drugs and Therapy | Issue 2/2010

Login to get access

Abstract

Purpose

We tested whether upregulation of hypoxia inducible factor-1 (HIF-1) would restore the blunted effects of natriuretic peptides and nitric oxide caused by chronic nitrate exposure and stunning in cardiac myocytes.

Methods

HIF-1α was increased with deferoxamine (150 mg/kg for 2 days). Nitrate tolerance was induced by a chronic nitroglycerin patch (0.3 mg/h for 5 days). We used freshly isolated rabbit ventricular myocytes. Half the myocytes were subjected to simulated ischemia [15 min 95% N2-5% CO2] and reperfusion [reoxygenation] to produce stunning. Cell function was measured utilizing a video-edge detector. Shortening was examined at baseline and after brain natriuretic peptide (BNP, 10−8, 10−7 M) or S-nitroso-N-acetyl-penicillamine (SNAP, 10−6, 10−5 M) followed by KT5823 (cyclic GMP protein kinase inhibitor, 10−6 M). We also measured cyclic GMP protein kinase protein levels and kinase activity.

Results

In control, BNP (−29%) reduced percent shortening, while KT5823 partially restored function. Deferoxamine treated control myocytes responded similarly. In patched nonstunned myocytes, BNP (−12%) reduced shortening less and KT5823 did not increase function. However, deferoxamine restored the blunted effects of BNP (−21%) and KT5823. In stunned myocytes, BNP (−11%) reduced shortening less and KT5823 did not affect function. Deferoxamine increased the effects of BNP (−27%) and KT5823 in stunning. Patch combined with stunning also similarly blunted the effects of BNP (−12%) and KT5823. Deferoxamine improved the effects of BNP (−22%) and KT5823. Similar results were observed after SNAP. Stunning reduced cyclic GMP protein kinase activity and deferoxamine restored activity. Deferoxamine had no effect on kinase activity in nitrate tolerance.

Conclusion

We found that upregulation of HIF-1 could protect isolated cardiac myocytes against nitrate tolerance through a cyclic GMP protein kinase-independent mechanism and through a kinase-dependent mechanism in stunning.
Literature
1.
go back to reference Murad F. Cellular signaling with nitric oxide and cyclic GMP. Braz J Med Biol Res. 1999;32:1317–27.PubMed Murad F. Cellular signaling with nitric oxide and cyclic GMP. Braz J Med Biol Res. 1999;32:1317–27.PubMed
2.
go back to reference Thadani U. Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure. Cardiovasc Drugs Ther. 1997;10:735–42.CrossRefPubMed Thadani U. Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure. Cardiovasc Drugs Ther. 1997;10:735–42.CrossRefPubMed
3.
go back to reference Shah AM, MacCarthy PA. Paracrine and autocrine effects of nitric oxide on myocardial function. Pharmacol Ther. 2000;86:49–86.CrossRefPubMed Shah AM, MacCarthy PA. Paracrine and autocrine effects of nitric oxide on myocardial function. Pharmacol Ther. 2000;86:49–86.CrossRefPubMed
4.
go back to reference Tan T, Zhang Q, Anyadike C, Scholz PM, Weiss HR. Chronic nitrates blunt the effects of not only nitric oxide but also natriuretic peptides in cardiac myocytes. Pharmacol Res. 2007;56:49–55.CrossRefPubMed Tan T, Zhang Q, Anyadike C, Scholz PM, Weiss HR. Chronic nitrates blunt the effects of not only nitric oxide but also natriuretic peptides in cardiac myocytes. Pharmacol Res. 2007;56:49–55.CrossRefPubMed
5.
go back to reference Munzel T, Daiber A, Mulsch A. Explaining the phenomenon of nitrate tolerance. Circ Res. 2005;97:618–28.CrossRefPubMed Munzel T, Daiber A, Mulsch A. Explaining the phenomenon of nitrate tolerance. Circ Res. 2005;97:618–28.CrossRefPubMed
6.
go back to reference Heyndrickx GR. Myocardial stunning: an experimental act with a large clinical audience. Arch Mal Coeur Vaiss. 2003;96:665–70.PubMed Heyndrickx GR. Myocardial stunning: an experimental act with a large clinical audience. Arch Mal Coeur Vaiss. 2003;96:665–70.PubMed
7.
go back to reference Anyadike C, Scholz PM, Zhang Q, Katz E, Weiss HR. Brain natriuretic peptide reverses the effects of myocardial stunning in rabbit myocardium. Pharmacology. 2007;80:40–8.CrossRefPubMed Anyadike C, Scholz PM, Zhang Q, Katz E, Weiss HR. Brain natriuretic peptide reverses the effects of myocardial stunning in rabbit myocardium. Pharmacology. 2007;80:40–8.CrossRefPubMed
8.
go back to reference Zhang Q, Lazar M, Yan L, et al. Cyclic GMP reduces myocardial stunning through non-cyclic GMP protein kinase mechanisms. J Cardiovasc Pharmacol. 2004;44:235–43.CrossRefPubMed Zhang Q, Lazar M, Yan L, et al. Cyclic GMP reduces myocardial stunning through non-cyclic GMP protein kinase mechanisms. J Cardiovasc Pharmacol. 2004;44:235–43.CrossRefPubMed
9.
go back to reference Dery MA, Michaud MD, Richard DE. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol. 2005;37:535–40.CrossRefPubMed Dery MA, Michaud MD, Richard DE. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol. 2005;37:535–40.CrossRefPubMed
10.
go back to reference Poellinger L, Johnson RS. HIF-1 and hypoxic response: the plot thickens. Curr Opin Genet Dev. 2004;14:81–5.CrossRefPubMed Poellinger L, Johnson RS. HIF-1 and hypoxic response: the plot thickens. Curr Opin Genet Dev. 2004;14:81–5.CrossRefPubMed
11.
go back to reference Semenza GL. O2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1. J Appl Physiol. 2004;96:1173–7. discussion 0–2.CrossRefPubMed Semenza GL. O2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1. J Appl Physiol. 2004;96:1173–7. discussion 0–2.CrossRefPubMed
12.
go back to reference Luciano JA, Tan T, Zhang Q, Huang E, Scholz P, Weiss HR. Hypoxia inducible factor-1 improves the actions of nitric oxide and natriuretic peptides after simulated ischemia-reperfusion. Cell Physiol Biochem. 2008;21:421–8.CrossRefPubMed Luciano JA, Tan T, Zhang Q, Huang E, Scholz P, Weiss HR. Hypoxia inducible factor-1 improves the actions of nitric oxide and natriuretic peptides after simulated ischemia-reperfusion. Cell Physiol Biochem. 2008;21:421–8.CrossRefPubMed
13.
go back to reference Su J, Zhang Q, Moalem J, Tse J, Scholz PM, Weiss HR. Functional effects of C-type natriuretic peptide and nitric oxide are attenuated in hypertrophic myocytes from pressure-overloaded mouse hearts. Am J Physiol Heart Circ Physiol. 2005;288:H1367–73.CrossRefPubMed Su J, Zhang Q, Moalem J, Tse J, Scholz PM, Weiss HR. Functional effects of C-type natriuretic peptide and nitric oxide are attenuated in hypertrophic myocytes from pressure-overloaded mouse hearts. Am J Physiol Heart Circ Physiol. 2005;288:H1367–73.CrossRefPubMed
14.
go back to reference Zhu H, Cai C, Chen J. Suppression of P-glycoprotein gene expression in Hs578T/Dox by the overexpression of caveolin-1. FEBS letters. 2004;576:369–74.CrossRefPubMed Zhu H, Cai C, Chen J. Suppression of P-glycoprotein gene expression in Hs578T/Dox by the overexpression of caveolin-1. FEBS letters. 2004;576:369–74.CrossRefPubMed
15.
go back to reference Ziolo MT, Kohr MJ, Wang H. Nitric oxide signaling and the regulation of myocardial function. J Mol Cell Cardiol. 2008;45:625–32.CrossRefPubMed Ziolo MT, Kohr MJ, Wang H. Nitric oxide signaling and the regulation of myocardial function. J Mol Cell Cardiol. 2008;45:625–32.CrossRefPubMed
16.
go back to reference Yan L, Zhang Q, Scholz PM, Weiss HR. Cyclic GMP protein kinase activity is reduced in thyroxine-induced hypertrophic cardiac myocytes. Clin Exp Pharmacol Physiol. 2003;30:943–50.CrossRefPubMed Yan L, Zhang Q, Scholz PM, Weiss HR. Cyclic GMP protein kinase activity is reduced in thyroxine-induced hypertrophic cardiac myocytes. Clin Exp Pharmacol Physiol. 2003;30:943–50.CrossRefPubMed
17.
go back to reference Francis SH, Blount MA, Zoraghi R, Corbin JD. Molecular properties of mammalian proteins that interact with cGMP: protein kinases, cation channels, phosphodiesterases, and multi-drug anion transporters. Front Biosci. 2005;10:2097–117.CrossRefPubMed Francis SH, Blount MA, Zoraghi R, Corbin JD. Molecular properties of mammalian proteins that interact with cGMP: protein kinases, cation channels, phosphodiesterases, and multi-drug anion transporters. Front Biosci. 2005;10:2097–117.CrossRefPubMed
18.
go back to reference Kojda G, Kottenberg K. Regulation of basal myocardial function by NO. Cardiovasc Res. 1999;41:514–23.CrossRefPubMed Kojda G, Kottenberg K. Regulation of basal myocardial function by NO. Cardiovasc Res. 1999;41:514–23.CrossRefPubMed
19.
go back to reference Klemenska E, Beresewicz A. Bioactivation of organic nitrates and the mechanism of nitrate tolerance. Cardiol J. 2009;16:11–9.PubMed Klemenska E, Beresewicz A. Bioactivation of organic nitrates and the mechanism of nitrate tolerance. Cardiol J. 2009;16:11–9.PubMed
20.
21.
go back to reference Mulsch A, Oelze M, Kloss S, et al. Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aorta. Circulation. 2001;103:2188–94.PubMed Mulsch A, Oelze M, Kloss S, et al. Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aorta. Circulation. 2001;103:2188–94.PubMed
22.
go back to reference Sage PR, de la Lande IS, Stafford I, et al. Nitroglycerin tolerance in human vessels: evidence for impaired nitroglycerin bioconversion. Circulation. 2000;102:2810–5.PubMed Sage PR, de la Lande IS, Stafford I, et al. Nitroglycerin tolerance in human vessels: evidence for impaired nitroglycerin bioconversion. Circulation. 2000;102:2810–5.PubMed
23.
go back to reference Warnholtz A, Tsilimingas N, Wendt M, Munzel T. Mechanisms underlying nitrate-induced endothelial dysfunction: insight from experimental and clinical studies. Heart Fail Rev. 2002;7:335–45.CrossRefPubMed Warnholtz A, Tsilimingas N, Wendt M, Munzel T. Mechanisms underlying nitrate-induced endothelial dysfunction: insight from experimental and clinical studies. Heart Fail Rev. 2002;7:335–45.CrossRefPubMed
25.
go back to reference Gowda RM, Khan IA, Vasavada BC, Sacchi TJ. Reversible myocardial dysfunction: basics and evaluation. Int J Cardiol. 2004;97:349–53.CrossRefPubMed Gowda RM, Khan IA, Vasavada BC, Sacchi TJ. Reversible myocardial dysfunction: basics and evaluation. Int J Cardiol. 2004;97:349–53.CrossRefPubMed
26.
go back to reference Weiss HR, Gandhi A, Scholz PM. Negative effect of nitric oxide on shortening-frequency relationship in cardiac myocytes is diminished after simulated ischemia-reperfusion. Basic Res Cardiol. 2003;98:311–8.CrossRefPubMed Weiss HR, Gandhi A, Scholz PM. Negative effect of nitric oxide on shortening-frequency relationship in cardiac myocytes is diminished after simulated ischemia-reperfusion. Basic Res Cardiol. 2003;98:311–8.CrossRefPubMed
27.
go back to reference Hannan RL, John MC, Kouretas PC, Hack BD, Matherne GP, Laubach VE. Deletion of endothelial nitric oxide synthase exacerbates myocardial stunning in an isolated mouse heart model. J Surg Res. 2000;93:127–32.CrossRefPubMed Hannan RL, John MC, Kouretas PC, Hack BD, Matherne GP, Laubach VE. Deletion of endothelial nitric oxide synthase exacerbates myocardial stunning in an isolated mouse heart model. J Surg Res. 2000;93:127–32.CrossRefPubMed
28.
go back to reference Brune B, Zhou J. Nitric oxide and superoxide: interference with hypoxic signaling. Cardiovasc Res. 2007;75:275–82.CrossRefPubMed Brune B, Zhou J. Nitric oxide and superoxide: interference with hypoxic signaling. Cardiovasc Res. 2007;75:275–82.CrossRefPubMed
29.
go back to reference Shrivastava K, Shukla D, Bansal A, Sairam M, Banerjee PK, Ilavazhagan G. Neuroprotective effect of cobalt chloride on hypobaric hypoxia-induced oxidative stress. Neurochem Int. 2008;52:368–75.CrossRefPubMed Shrivastava K, Shukla D, Bansal A, Sairam M, Banerjee PK, Ilavazhagan G. Neuroprotective effect of cobalt chloride on hypobaric hypoxia-induced oxidative stress. Neurochem Int. 2008;52:368–75.CrossRefPubMed
30.
go back to reference Kirito K, Hu Y, Komatsu N. HIF-1 prevents the overproduction of mitochondrial ROS after cytokine stimulation through induction of PDK-1. Cell Cycle. 2009;8:2844–9.PubMed Kirito K, Hu Y, Komatsu N. HIF-1 prevents the overproduction of mitochondrial ROS after cytokine stimulation through induction of PDK-1. Cell Cycle. 2009;8:2844–9.PubMed
Metadata
Title
Hypoxia Inducible Factor-1 Protects Against Nitrate Tolerance and Stunning in Rabbit Cardiac Myocytes
Authors
Tao Tan
Harvey R. Weiss
Publication date
01-04-2010
Publisher
Springer US
Published in
Cardiovascular Drugs and Therapy / Issue 2/2010
Print ISSN: 0920-3206
Electronic ISSN: 1573-7241
DOI
https://doi.org/10.1007/s10557-010-6229-9

Other articles of this Issue 2/2010

Cardiovascular Drugs and Therapy 2/2010 Go to the issue